Myomo (MYO) Long-Term Investments (2022 - 2023)
Myomo's (MYO) quarterly Long-Term Investments came in at $32648.0 in Q3 2023, down 78.11% YoY from $149140.0 in Q3 2022, and down 68.23% on a QoQ basis from $102773.0 in Q2 2023.
Myomo (MYO) Long-Term Investments (2022 - 2023) Analysis & Trends
Myomo (MYO) has 2 years of Long-Term Investments data on file, last reported at $32648.0 in Q3 2023.
- Quarterly Long-Term Investments fell 78.11% year-over-year to $32648.0 in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $32648.0 (down 78.11% YoY) and the FY2022 annual result came in at $132489.0, changed N/A from the prior year.
- Long-Term Investments fell to $32648.0 in Q3 2023, from $102773.0 in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $199000.0 in Q1 2022 to a low of $32648.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 1.11 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 2.25 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 244.10 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 175.52 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | - |
| 10 | Myomo | 67.26 Mn | 48.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 32,648.00 |
| Jun 30, 2023 | 102,773.00 |
| Mar 31, 2023 | 115,287.00 |
| Dec 31, 2022 | 132,489.00 |
| Sep 30, 2022 | 149,140.00 |
| Jun 30, 2022 | 165,792.00 |
| Mar 31, 2022 | 199,000.00 |